Skip to main content

Month: August 2024

Intapp Announces Fourth Quarter and Fiscal Year 2024 Financial Results

Fourth quarter SaaS and support revenue of $85.0 million, up 25% year-over-year Fourth quarter total revenue of $114.4 million, up 21% year-over-year Cloud annual recurring revenue (ARR) of $296.7 million, up 33% year-over-yearPALO ALTO, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) — Intapp, Inc. (NASDAQ: INTA), a leading global provider of AI-powered solutions for professionals at advisory, capital markets, and legal firms, announced financial results for its fourth quarter and fiscal year ended June 30, 2024. Intapp also provided its outlook for the first quarter and fiscal year 2025. “It has been a strong and exciting year for Intapp as we lead our clients to adopt and apply AI to the work of their professionals,” said John Hall, CEO of Intapp. “Our fiscal year 2024 results reflect the launch of our innovative new AI solutions,...

Continue reading

Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Advanced to Cohort 6 in the Phase 1 dose-escalation clinical study of BDC-3042 in patients with advanced cancers Abstract accepted for BDC-4182, a claudin 18.2-targeting BoltbodyTM ISAC at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting Cash balance of $97.5 million as of June 30, 2024 anticipated to fund key milestones through mid-2026REDWOOD CITY, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today reported financial results for the second quarter ended June 30, 2024, and provided a business update. “During the second quarter, we continued to make significant progress across our two programs, BDC-3042 and BDC-4182, following our strategic pipeline prioritization in May,”...

Continue reading

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024

PORTLAND, Maine, Aug. 13, 2024 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial results for the quarter ended June 30, 2024. Q2 2024 Highlights:Product sales increased 55% versus the comparable quarter in 2023. Product sales increased 82% versus the comparable six-month period in 2023. Product sales increased 48% from the previous trailing twelve-month period ended June 30, 2023.Management’s Discussion:“Our preliminary, unaudited product sales for the second quarter of 2024 were first reported on July 9, 2024,” commented Michael F. Brigham, President and CEO of ImmuCell....

Continue reading

Nokia Corporation: Repurchase of own shares on 13.08.2024

Nokia CorporationStock Exchange Release13 August 2024 at 22:30 EET Nokia Corporation: Repurchase of own shares on 13.08.2024 Espoo, Finland – On 13 August 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 1,469,218 3.54CEUX 733,240 3.54BATE – –AQEU – –TQEX – –Total 2,202,458 3.54* Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program started on 20 March 2024. On 19 July 2024, Nokia decided to accelerate the share buybacks by increasing...

Continue reading

Table Trac, Inc. Reports 2024 Second Quarter Earnings

MINNETONKA, Minn., Aug. 13, 2024 (GLOBE NEWSWIRE) — Table Trac, Inc. (OTCQX: TBTC), a developer and provider of casino information and management systems that automate and monitor the operations of casinos, announced financial results for the three and six months ending June 30, 2024. The 10-Q can be found @ http://www.sec.gov Second Quarter 2024 HighlightsThe Company installed two systems, our distributors expanded our system in new and current locations during the quarter.The Company has four customer contracts in backlog as of June 30, 2024. The company anticipates that the majority of these contracts will be installed in the next two quarters. As of the filing date of this report, the Company has signed one new contract.Financial Results System revenue for the quarter was $2M compared to $907K in 2023, an increase of...

Continue reading

Professional Diversity Network, Inc. Announces Financial Results for the Quarter Ended June 30, 2024

CHICAGO, Aug. 13, 2024 (GLOBE NEWSWIRE) — Professional Diversity Network, Inc. (NASDAQ:IPDN), (“IPDN” or the “Company”), a global developer and operator of online and in-person networks that provides access to networking, training, educational and employment opportunities for diverse individuals, today announced its financial results for the quarter ended June 30, 2024. “The current recruiting market presents significant challenges. However, our recruitment services experienced a 3.2% revenue increase during the first two quarters of this year compared to the same period last year, demonstrating the effectiveness of our operational restructuring efforts. We remain committed to strategically targeting industries to establish ourselves as a leader in the diversity recruitment sector. RemoteMore has faced a slow demand for IT...

Continue reading

GWTI SIGNS NEW SRA AS PART OF THEIR PATENT AGREEMENT WITH UTA

ARLINGTON, Texas, Aug. 13, 2024 (GLOBE NEWSWIRE) — Greenway Technologies, Inc. (OTC: GWTI), (“Greenway”), an advanced gas-to-liquids (“GTL”) and gas-to-hydrogen (“GTH”) technology development company, announces that it has signed a new Sponsored Research Agreement (SRA) with the University of Texas-Arlington (UTA) as part of their existing mutual patent agreement. The agreement between Greenway and UTA, an SRA, outlines and defines specific tasks to be performed by UTA on behalf of Greenway. The agreement also upgrades GWTI’s patent rights for discoveries made under the SRA. UTA agrees to research Greenway’s GTL and GTH products and provide the research to Greenway, including all patent rights and other discoveries made due to the ongoing research. In addition to tasks to be performed, the SRA defines a specific time frame for...

Continue reading

Tilray Brands to Acquire Four Craft Beer Breweries from Molson Coors Beverage Company

Tilray’s Strategic Acquisition Will Strengthen its Craft Beer Leadership in the U.S. and Solidify Tilray Beverages as the #1 Craft Brewer in the Pacific Northwest and #1 in Georgia; Anchors Tilray in Key Markets, Texas and Michigan Tilray’s Beverage Division Projected to Grow New Beer Accounts by 30% NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle consumer packaged goods company elevating lives through moments of connection, today announced that the Company has entered into a definitive agreement to acquire four craft breweries from Molson Coors Beverage Company (“Molson Coors”) (NYSE: TAP). The acquisition includes Hop Valley Brewing Company, Terrapin Beer Co., Revolver Brewing, and Atwater Brewery. Tilray’s beverage business...

Continue reading

Pixel 9 on Verizon: Powered by Gemini AI and 5G Ultra Wideband to make your life easier

Preorders start today What you need to know:Preorder the Pixel 9 smartphone family on Verizon today. Current and new customers can get a Pixel 9 on us, or up to $800 off a new Pixel 9 series smartphone, with a qualified trade-in. In any condition. Guaranteed. With Unlimited Ultimate1. For a limited time, get a free memory upgrade when you order your Pixel 9 or Pixel 9 Pro XL3.NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) — Verizon is thrilled to be the home of the new Google Pixel 9 family. All four new phones are packed with the latest and greatest tech, so you can get all your stuff done seamlessly. With a sleek design, incredible AI features and the power of Verizon’s 5G, the Google Pixel 9 series is the ultimate smartphone for staying connected, getting work done and having a blast in your free time. Plus, we’re buzzing with...

Continue reading

Bavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its Chikungunya Vaccine

PDUFA target action date of February 14, 2025COPENHAGEN, Denmark, August 13, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the Biologics License Application (BLA) for CHIKV VLP, the Company’s vaccine candidate for immunization to prevent disease caused by chikungunya virus infection in individuals 12 years of age and older. The Priority Review designation means the FDA is targeting completion of its review within six months, compared to 10 months under standard review, and thus has assigned a Prescription Drug User Free Act (PDUFA) target action date of February 14, 2025. “We are encouraged by the FDA’s decision to grant Priority Review to our chikungunya vaccine, allowing for a shorter review time, and we look forward to working closely...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.